对我国成本效果阈值确定方法的思考  

Considerations of methods for determining cost-effectiveness threshold in China

作　　者：宗欣[1] 孙利华[1] 

机构地区：[1]沈阳药科大学工商管理学院,沈阳110016

出　　处：《中国新药杂志》2012年第24期2857-2860,共4页Chinese Journal of New Drugs

摘　　要：目的:对成本效果阈值现有的主要确定方法进行分析,寻找适合我国的阈值确定方法,为我国成本效果阈值的确定及应用奠定基础。方法:通过文献综述的方法,对目前主要的成本效果阈值确定方法进行回顾分析和归纳总结,在此基础上找出适合我国的成本效果阈值确定方法。结果:社会意愿支付法、阈值寻找者模式、人均GDP法均对我国成本效果阈值的确定有重要的借鉴意义。结论:建议以阈值寻找者模式为主、以人均GDP法(社会意愿支付法)为参考来确定我国的成本效果阈值,在寻找我国的成本效果阈值期间,可暂时先借鉴人均GDP法确定的经济性评价标准。Objective： To analyze the main existing methods of cost-effectiveness threshold,and to provide the basis for the determination and use of cost-effectiveness threshold in China.Methods： The main existing methods were analyzed and reviewed retrospectively to find out the appropriate method（s） in China.Results： Social willing-to-pay approach,ICER threshold-searcher-model and GDP per capita approach were very important references to appropriately determine the cost-effectiveness threshold in China.Conclusion： The recommendation for appropriate determination of cost-effectiveness threshold in China is that the ICER threshold-searcher-model can be used as the main determining method,and the GDP per capita approach（social willing-to-pay approach） as the reference.We can temporarily use GDP per capita as a replacement of the real threshold.

关 键 词：成本效果阈值确定方法 社会意愿支付法 阈值寻找者模式 人均GDP法 

分 类 号：R95[医药卫生—药学]